CD34 and type 2 diabetes mellitus: In the same way, sitagliptin improved revascularization and angiogenesis in an T2DM murine model with HLI and could restore the detrimental effects of HGE in EPCs (CD34+KDR+), reducing the in vitro apoptosis and oxidative stress while increasing the tube formation ability and autophagy [181].